Clinical Trial Update: A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for AP-CD/LD in fluctuating Parkinson's disease patients who completed a prior study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AP-CD/LD

Snippet

Sponsor: Intec Pharma Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: UNKNOWN